Cumberland Pharmaceuticals Inc

NASDAQ:CPIXUnited States

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a prescription laxative, for the treatment of constipation, and Omeclamox-Pak, oral, for the treatment of Helicobacter pylori infection and related duodenal ulcer disease. Its brands also include Sancuso transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia, and Vibativ injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia.

Contact Information

Headquarters

2525 W End Ave Ste 950NASHVILLE, TN, United States 37203-1608

Phone

615-255-0068

Fax

615-255-0094

Executives

Chairman of the Board, Chief Executive Officer

A. Kazimi

Chief Financial Officer, Vice President

John Hamm

Senior Vice President, Chief Compliance Officer

James Herman

Vice President of Sales and Marketing

Chris Bitterman

Vice President - Organizational Development

Todd Anthony